Popular topics to explore
GLAND
Gland Pharma is in focus today after significant block-deal activity involving the company’s shares. Around 1.22 crore shares changed hands across two large block deals, with the transactions valued at approximately ₹2,941 crore and ₹2,877 crore, respectively. Market reports indicate that promoter Fosun Pharma Industrial was likely the seller, with the transactions coming amid reports of a potential reduction in its stake.
As of June 30, 2026, Fosun Pharma Industrial held approximately 51.77% of Gland Pharma. The reported stake sale represents a significant transaction involving the company’s promoter and has resulted in immediate market reaction, with Gland Pharma shares falling around 3% to ₹2,827 during Friday’s session. Investors will now be watching the final shareholding disclosures and whether there are any further changes in promoter ownership.#StockInNews#EquityResearch
857 likes·61 comments

















